Unknown

Dataset Information

0

Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks.


ABSTRACT: 18F-Fluorodeoxyglucose-positron emission tomography (FDG-PET) is commonly used in clinical practice and clinical drug development to identify and quantify metabolically active tumors. Manual or computer-assisted tumor segmentation in FDG-PET images is a common way to assess tumor burden, such approaches are both labor intensive and may suffer from high inter-reader variability. We propose an end-to-end method leveraging 2D and 3D convolutional neural networks to rapidly identify and segment tumors and to extract metabolic information in eyes to thighs (whole body) FDG-PET/CT scans. The developed architecture is computationally efficient and devised to accommodate the size of whole-body scans, the extreme imbalance between tumor burden and the volume of healthy tissue, and the heterogeneous nature of the input images. Our dataset consists of a total of 3664 eyes to thighs FDG-PET/CT scans, from multi-site clinical trials in patients with non-Hodgkin's lymphoma (NHL) and advanced non-small cell lung cancer (NSCLC). Tumors were segmented and reviewed by board-certified radiologists. We report a mean 3D Dice score of 88.6% on an NHL hold-out set of 1124 scans and a 93% sensitivity on 274 NSCLC hold-out scans. The method is a potential tool for radiologists to rapidly assess eyes to thighs FDG-avid tumor burden.

SUBMITTER: Jemaa S 

PROVIDER: S-EPMC7522127 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks.

Jemaa Skander S   Fredrickson Jill J   Carano Richard A D RAD   Nielsen Tina T   de Crespigny Alex A   Bengtsson Thomas T  

Journal of digital imaging 20200801 4


<sup>18</sup>F-Fluorodeoxyglucose-positron emission tomography (FDG-PET) is commonly used in clinical practice and clinical drug development to identify and quantify metabolically active tumors. Manual or computer-assisted tumor segmentation in FDG-PET images is a common way to assess tumor burden, such approaches are both labor intensive and may suffer from high inter-reader variability. We propose an end-to-end method leveraging 2D and 3D convolutional neural networks to rapidly identify and s  ...[more]

Similar Datasets

| S-EPMC8977865 | biostudies-literature
| S-EPMC7530079 | biostudies-literature
| S-EPMC7511465 | biostudies-literature
| S-EPMC6779234 | biostudies-literature
| S-EPMC6700294 | biostudies-literature
| S-EPMC7979624 | biostudies-literature
2023-12-18 | GSE244989 | GEO
| S-EPMC8342266 | biostudies-literature
| S-EPMC3460598 | biostudies-literature
| S-EPMC8750371 | biostudies-literature